Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00856986

Public ClinicalTrials.gov record NCT00856986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 9:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes. A 26 Week, Randomised, Open-label, Parallel-group, Multicentre, Multinational Trial With a 26 Week Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe and North America. The aim of this clinical trial is to assess and compare the effect of insulin detemir in combination with liraglutide and metformin versus liraglutide and metformin in subjects with type 2 diabetes. Subjects will continue their own pre-trial metformin treatment during the trial.

Study identification

NCT ID
NCT00856986
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
987 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 84 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2009 (Type not available)
Primary completion
Apr 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Mar 8, 2017

2009 – 2010

United States locations

U.S. sites
60
U.S. states
21
U.S. cities
52
Facility City State ZIP Site status
Novo Nordisk Investigational Site Alexander City Alabama 35010 —
Novo Nordisk Investigational Site Birmingham Alabama 35294 —
Novo Nordisk Investigational Site Encino California 91436 —
Novo Nordisk Investigational Site Fullerton California 92835 —
Novo Nordisk Investigational Site Inglewood California 90301 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Los Gatos California 95032 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site Spring Valley California 91978 —
Novo Nordisk Investigational Site Tustin California 92780 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Waterbury Connecticut 06712 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Clearwater Florida 33765 —
Novo Nordisk Investigational Site Jupiter Florida 33458-7200 —
Novo Nordisk Investigational Site Miami Florida 33136 —
Novo Nordisk Investigational Site Miami Florida 33156 —
Novo Nordisk Investigational Site Miami Florida 33169 —
Novo Nordisk Investigational Site Atlanta Georgia 30308-2253 —
Novo Nordisk Investigational Site Decatur Georgia 30033 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Savannah Georgia 31405 —
Novo Nordisk Investigational Site Chicago Illinois 60616 —
Novo Nordisk Investigational Site Quincy Illinois 62301 —
Novo Nordisk Investigational Site Chicago Heights Indiana 60411 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Madisonville Kentucky 42431 —
Novo Nordisk Investigational Site Baltimore Maryland 21204 —
Novo Nordisk Investigational Site Hyattsville Maryland 20782 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Methuen Massachusetts 01844 —
Novo Nordisk Investigational Site St Louis Missouri 63104 —
Novo Nordisk Investigational Site New Hyde Park New York 11042 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site Syracuse New York 13210 —
Novo Nordisk Investigational Site The Bronx New York 10461-2665 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Durham North Carolina 27710 —
Novo Nordisk Investigational Site Cincinnati Ohio 45226 —
Novo Nordisk Investigational Site Cincinnati Ohio 45245 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103 —
Novo Nordisk Investigational Site Danville Pennsylvania 17822 —
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19152 —
Novo Nordisk Investigational Site State College Pennsylvania 16801 —
Novo Nordisk Investigational Site Willkes Barre Pennsylvania 18702 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Memphis Tennessee 38119 —
Novo Nordisk Investigational Site Corpus Christi Texas 78412 —
Novo Nordisk Investigational Site Dallas Texas 75230 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75235-6233 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75390-9302 —
Novo Nordisk Investigational Site Midland Texas 79707 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site Orem Utah 84058 —
Novo Nordisk Investigational Site Richmond Virginia 23249 —
Novo Nordisk Investigational Site Richmond Virginia 23294 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 173 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00856986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00856986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →